Key Statistics for Acute Myeloid Leukemia (AML)
The American Cancer Society’s estimates for leukemia in the United States for 2023 are:
- About 59,610 new cases of leukemia (all kinds) and 23,710 deaths from leukemia (all kinds)
- About 20,380 new cases of acute myeloid leukemia (AML). Most will be in adults.
- About 11,310 deaths from AML. Almost all will be in adults.
AML is one of the most common types of leukemia in adults. Still, AML is fairly rare overall, accounting for only about 1% of all cancers.
AML is generally a disease of older people and is uncommon before the age of 45. The average age of people when they are first diagnosed with AML is about 68. But AML can occur in children as well.
AML is slightly more common among men than women, but the average lifetime risk of getting AML in both sexes is about ½ of 1%.
Information on treatment success rates for AML in adults can be found in Treatment Response Rates for Acute Myeloid Leukemia.
Visit the American Cancer Society’s Cancer Statistics Center for more key statistics.
- Written by
- References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
American Cancer Society. Cancer Facts & Figures 2023. Atlanta, Ga: American Cancer Society; 2023.
National Cancer Institute. SEER Cancer Stat Facts: Acute Myeloid Leukemia. Accessed at https://seer.cancer.gov/statfacts/html/amyl.html on June 12, 2018.
Last Revised: January 12, 2023
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Our lifesaving work is made possible thanks to generous supporters like you.
Donate now so we can continue to provide access to critical cancer information, resources, and support to improve lives of people with cancer and their families.
More in Acute Myeloid Leukemia
Help us end cancer as we know it, for everyone.
